Biocryst Pharmaceuticals BCRX Cash Flow Statement (2010-2026)

NASDAQ BCRX
$9.18 +0.12 (+1.27%)
As of: Sep 9, 2026 · 2:47 PM EDT
Reported Financials

Biocryst Pharmaceuticals Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Biocryst Pharmaceuticals reported cash from operations of $104.34M and free cash flow of $104.34M for the quarter ended Jun 2026, up 152.6% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-58.80M-17.78M-74.20M-58.86M-42.52M-71.54M-53.33M-75.33M-36.15M-61.73M-35.38M-12.67M-14.03M-26.80M0.03M5.08M12.90M245.84M-721.81M78.39M
Share-based CompensationStock Comp.
60.42M8.50M27.39M9.87M9.95M15.28M14.01M12.84M12.28M16.49M13.65M13.17M17.25M21.34M21.37M21.30M18.60M23.79M16.03M14.69M
Asset Writedowns and ImpairmentWritedown
0.93M0.24M0.00M-0.00M1.31M0.00M1.36M-0.01M0.21M0.82M0.03M-0.07M0.07M0.51M
Cash from OperationsCash from Ops.
-23.28M-32.46M-77.80M-27.76M-32.44M-23.85M-47.51M-18.81M-19.90M-8.92M-53.68M-1.37M8.24M-5.21M-27.52M41.30M41.62M291.96M-61.79M104.34M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
-1.39M-2.83M-2.60M-3.45M-3.18M-3.49M-2.04M-2.76M-1.38M-1.15M-0.71M-1.09M0.25M-0.42M
Amortization of Deferred ChargesAmort. Deferred Charges
13.78M17.76M19.00M17.72M18.39M43.80M20.22M23.72M22.35M
Depreciation & Amortization (CF)Dep. & Amort.
0.23M0.17M0.32M0.34M0.39M0.40M0.41M0.41M0.42M0.42M0.31M0.32M0.31M0.31M0.33M0.33M0.34M0.39M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.40M3.24M7.05M5.29M1.48M7.64M-2.02M8.99M-3.84M2.97M3.84M8.25M3.32M7.30M13.99M7.31M0.02M15.49M0.47M1.49M
Change in InventoryChange Inventory
3.82M2.14M0.35M7.24M3.67M1.16M-0.13M-0.90M3.39M-0.91M1.22M-0.74M1.52M2.16M0.87M-1.44M1.69M0.52M4.85M4.35M
Change in Account PayablesChange Payables
13.95M22.72M-22.91M14.45M-19.18M5.28M-27.23M-0.19M-9.26M49.21M-44.57M20.54M18.41M20.40M-32.59M30.46M24.58M35.36M-60.40M5.07M
Change in Accured ExpensesChange Accured Exp.
0.34M0.28M6.34M-6.34M
Other Working Capital ChangesOther WC Changes
0.05M0.83M0.07M0.11M0.14M-0.44M-0.04M0.57M-1.35M-0.42M-0.75M11.54M
Investing Activities
Capital ExpendituresCapex
0.36M1.11M0.41M0.24M0.17M0.53M0.16M0.47M0.99M0.55M0.23M0.15M0.06M0.68M0.14M0.18M1.34M0.80M0.61M0.00M
Acquisitions
489.48M
Change in Acquisitions & DivestmentsChange Acquisitions
8.11M4.00M35.66M77.74M41.69M66.33M148.00M129.07M117.00M110.00M35.48M58.00M76.00M58.65M73.00M49.00M221.24M25.70M
Cash from Investing ActivitiesCash from Investing
7.75M-11.12M-38.47M-97.44M-69.54M77.22M-107.11M-19.04M23.12M-28.47M28.76M-2.45M8.49M17.80M27.09M29.13M13.57M-83.49M-268.65M-110.15M
Financing Activities
Other financing activitiesOther financing
4.78M3.48M7.36M0.15M3.25M4.01M5.08M1.75M1.48M0.04M1.68M0.26M2.08M-0.59M2.39M3.42M2.65M0.66M19.48M6.20M
Cash from Financing ActivitiesCash from Financing
4.78M347.42M7.36M0.15M76.33M4.20M5.08M29.36M1.23M-3.17M-1.05M-1.97M1.27M-4.02M0.53M-73.69M-58.81M-217.96M412.55M-11.15M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
7.76M0.37M
Net Equity Issued and RepurchasedNet Equity Issued
50.00M
Additional items
Exchange Rate EffectFX Effect
-0.02M0.00M0.04M0.21M-0.01M0.33M-0.10M-0.32M0.25M0.52M-0.34M-0.14M0.85M-1.30M0.45M1.36M-0.47M-0.07M-0.07M-0.04M
Change in Cash
-10.77M303.84M-108.88M-124.84M-25.68M57.90M-149.64M-8.81M4.70M-40.04M-26.32M-5.93M18.86M7.26M0.56M-16.96M10.97M-9.56M82.04M-16.99M
Free Cash FlowFCF
-23.64M-33.57M-78.21M-28.00M-32.62M-24.38M-47.67M-19.28M-20.88M-9.47M-53.92M-1.52M8.19M-5.89M-27.66M41.12M40.28M291.16M-62.40M104.34M
Net Cash FlowNCF
-10.75M303.84M-108.92M-125.05M-25.66M57.56M-149.54M-8.49M4.45M-40.56M-25.98M-5.78M18.01M8.56M0.11M-3.26M-3.62M-9.49M82.11M-16.96M